|
|
|
|
|
|
| Galderma completes acquisition of Collagenex
Friday, April 11, 2008Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company, Galderma Laboratories, Inc., has completed its acquisition of CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI). |
| Galderma completes tender offer for Collagenex
Monday, April 07, 2008Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company, Galderma Laboratories, Inc., has completed its all cash tender offer for CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI). |
| Galderma reaches agreement to acquire Collagenex Pharmaceuticals
Tuesday, February 26, 2008Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, and CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI) today announced a definitive agreement pursuant to which Galderma’s U.S. holding company, Galderma Laboratories, Inc., will acquire all of the outstanding shares of CollaGenex at a price of $16.60 per share in cash, representing approximately $420 million for the equity of CollaGenex. |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|